<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01592513</url>
  </required_header>
  <id_info>
    <org_study_id>rmc116633CTIL</org_study_id>
    <nct_id>NCT01592513</nct_id>
  </id_info>
  <brief_title>Effect of BIS Monitoring on Propofol Usage During Elective Bronchoscopy</brief_title>
  <official_title>Effect of BIS Monitoring on Propofol Usage During Elective Bronchoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this research, the investigators will asses the effect of BIS monitoring on propofol usage
      during elective flexible fiberoptic bronchoscopy.

      The investigators will examine whether use of BIS monitor enables reduction of sedative dose
      during bronchoscopy.

      The investigators will also examine whether administration of lower total sedative dose
      enables prevention of possible complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During flexible fiberoptic bronchoscopy (FFP) a narrow optic tube is inserted via the mouth
      or nose into the airways. This allows direct visualization of the airways as well as taking
      different samples. In addition, this procedure allows opening of airway obstruction.

      Administration of sedation during FFP is important, since this diminishes patient discomfort
      and body movements. It also lessens the untoward physiologic response to airway manipulation.
      In addition, patients requiring repeated examinations may refuse if they have suffered an
      unpleasant experience.

      FFP is usually a brief procedure (several minutes up to an hour). Therefore, it is
      advantageous to use short acting drugs in order to shorten the prolonged post procedural
      monitoring and allow rapid patient discharge.

      Several clinical trials have shown the superiority of propofol over midazolam for sedation
      during bronchoscopy regarding recovery of alertness, memory &amp; motor function.

      Propofol is a sedative-hypnotic with rapid onset and short duration. Using propofol, one can
      achieve rapid onset of sedation and faster recovery.

      Propofol given in boluses of 10-20 mg was found as an effective dose to reach BIS target
      values.

      Awareness is the postoperative recollection of events occurring during general anesthesia.

      BIS is a monitor of anesthetic depth approved by the FDA. It incorporates time-domain,
      frequency-domain and bi-spectral analysis of the EEG. This analysis is displayed as a
      dimensionless number between zero (deep anesthesia) and 100 (awake).

      BIS values between 80-90 represent values corresponding to light/moderate sedation
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">October 2012</completion_date>
  <primary_completion_date type="Anticipated">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total sedative dose in mg.</measure>
    <time_frame>Duration of flexible fiberoptic bronchoscopy (an average of 30 minutes)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentages of patients which developed complications resulting from use of sedatives</measure>
    <time_frame>Duration of flexible fiberoptic bronchoscopy (an average of 30 minutes) up to 10 minutes after completion of procedure</time_frame>
    <description>The investigators will assess the occurrence of the following complications: hemodynamic instability, hypoxemia, respiratory depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentages of awareness during flexible fiberoptic bronchoscopy</measure>
    <time_frame>Duration of flexible fiberoptic bronchoscopy (an average of 30 minutes)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Pulmonary Diseases</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>BIS monitor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will be monitored by BIS (placement of an electrode over the forehead before sedation).
Patients in this group will receive propofol (boluses of 10-20 mg) to reach a BIS target value of 80-90.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BIS monitor</intervention_name>
    <description>BIS is a monitor of anesthetic depth approved by the FDA. It incorporates time-domain, frequency-domain and bi-spectral analysis of the EEG. This analysis is displayed as a dimensionless number between zero (deep anesthesia) and 100 (awake).
BIS values between 80-90 represent values corresponding to light/moderate sedation.
BIS is a valuable tool for assessing the depth of sedation and guiding the administration of sedative drugs.</description>
    <arm_group_label>BIS monitor</arm_group_label>
    <other_name>BIS monitor by Covidien - aspectmedical</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 years old

          -  Undergoing flexible fiberoptic bronchoscopy for lung tissue biopsy, airway lavage or
             opening of airway obstruction.

        Exclusion Criteria:

          -  Patient refusal/ inability to sign informed consent.

          -  Age under 18 years of age.

          -  Ventilated patients (via endotracheal tube or tracheostomy).

          -  Known allergy for one of the anesthetic drugs.

          -  Patients who suffered a stroke and/or have other neurological diseases.

          -  Hemodynamically unstable patients (SBP below 90mmHg or above 180mmHg).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mordechai Kremer, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Head of pulmonolgy institute, Rabin Medical center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michal Tirosh, MD</last_name>
    <phone>+ 972547930667</phone>
    <email>michal.tirosh@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rabin Medical center</name>
      <address>
        <city>Petah Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Michal Tirosh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Myles PS, Leslie K, McNeil J, Forbes A, Chan MT. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet. 2004 May 29;363(9423):1757-63.</citation>
    <PMID>15172773</PMID>
  </reference>
  <reference>
    <citation>Clark G, Licker M, Younossian AB, Soccal PM, Frey JG, Rochat T, Diaper J, Bridevaux PO, Tschopp JM. Titrated sedation with propofol or midazolam for flexible bronchoscopy: a randomised trial. Eur Respir J. 2009 Dec;34(6):1277-83. doi: 10.1183/09031936.00142108. Epub 2009 May 14.</citation>
    <PMID>19443532</PMID>
  </reference>
  <reference>
    <citation>Bould MD, Mahtani DG, Davies R, Roughton M, Hunter DN, Kelleher A. Bispectral index values during elective rigid bronchoscopy: a prospective observational pilot study. Anaesthesia. 2007 May;62(5):438-45.</citation>
    <PMID>17448053</PMID>
  </reference>
  <reference>
    <citation>Yamamoto S, Igarashi T, Tetsuka K, Endo S. Bispectral index monitoring of midazolam sedation during flexible bronchoscopy. J Bronchology Interv Pulmonol. 2009 Oct;16(4):241-4. doi: 10.1097/LBR.0b013e3181bb781f.</citation>
    <PMID>23168586</PMID>
  </reference>
  <reference>
    <citation>Brice DD, Hetherington RR, Utting JE. A simple study of awareness and dreaming during anaesthesia. Br J Anaesth. 1970 Jun;42(6):535-42.</citation>
    <PMID>5423844</PMID>
  </reference>
  <results_reference>
    <citation>Carmi U, Kramer MR, Zemtzov D, Rosengarten D, Fruchter O. Propofol safety in bronchoscopy: prospective randomized trial using transcutaneous carbon dioxide tension monitoring. Respiration. 2011;82(6):515-21. doi: 10.1159/000331506. Epub 2011 Sep 16.</citation>
    <PMID>21934290</PMID>
  </results_reference>
  <results_reference>
    <citation>Tschopp JM, Purek L, Frey JG, Schnyder JM, Diaper J, Cartier V, Licker M. Titrated sedation with propofol for medical thoracoscopy: a feasibility and safety study. Respiration. 2011;82(5):451-7. doi: 10.1159/000329438. Epub 2011 Oct 13.</citation>
    <PMID>21996705</PMID>
  </results_reference>
  <results_reference>
    <citation>Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman AC, Selvidge JA, Saager L, Turner MS, Rao S, Bottros M, Hantler C, Jacobsohn E, Evers AS. Anesthesia awareness and the bispectral index. N Engl J Med. 2008 Mar 13;358(11):1097-108. doi: 10.1056/NEJMoa0707361.</citation>
    <PMID>18337600</PMID>
  </results_reference>
  <results_reference>
    <citation>I Matot, et al. Sedation in outpatient flexible bronchoscopy: alfentanil-propofol versus Meperidine-Midazolam. Journal of Bronchology &amp; interventional pulmonology 1999; 6:74-77.</citation>
  </results_reference>
  <results_reference>
    <citation>Mashour GA, Orser BA, Avidan MS. Intraoperative awareness: from neurobiology to clinical practice. Anesthesiology. 2011 May;114(5):1218-33. doi: 10.1097/ALN.0b013e31820fc9b6. Review.</citation>
    <PMID>21464699</PMID>
  </results_reference>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2012</study_first_submitted>
  <study_first_submitted_qc>May 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2012</study_first_posted>
  <last_update_submitted>May 3, 2012</last_update_submitted>
  <last_update_submitted_qc>May 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rabin Medical Center</investigator_affiliation>
    <investigator_full_name>Mordechai Kremer</investigator_full_name>
    <investigator_title>Head of pulmonology institute</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

